Top Institutions in Ophthalmology, Gene Therapy
Leading institutions in this area combine expertise in inherited retinal diseases, gene therapy vector development, and clinical trial execution for novel ocular gene therapies. They typically have specialized retinal genetics programs and collaborate closely with biotech companies developing AAV-based gene therapies.
-
#1
Massachusetts Eye and Ear Infirmary
Boston, MA
Massachusetts Eye and Ear is a global leader in inherited retinal disease research and gene therapy clinical trials, with pioneering work in RPGR gene therapy for XLRP and strong collaborations with biotech companies.
-
#2
Bascom Palmer Eye Institute, University of Miami
Miami, FL
Bascom Palmer has a renowned retinal genetics program and has been involved in multiple gene therapy trials for retinal dystrophies including XLRP, contributing significant clinical expertise and patient recruitment capabilities.
-
#3
Johns Hopkins Wilmer Eye Institute
Baltimore, MD
Wilmer Eye Institute is a leader in translational research for inherited retinal diseases and has contributed to the development and clinical testing of gene therapies targeting RPGR mutations.
-
#4
University of Pennsylvania Scheie Eye Institute
Philadelphia, PA
Scheie Eye Institute has a strong focus on gene therapy for retinal diseases and has been involved in early phase clinical trials for XLRP gene therapies, with expertise in vector design and patient phenotyping.